We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02633397
Recruitment Status : Completed
First Posted : December 17, 2015
Last Update Posted : July 13, 2022
Information provided by (Responsible Party):
Mark Gladwin, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 4, 2022
Actual Study Completion Date : May 4, 2022